In pooled follow-up data for 768 antithrombotic users , presence of MB at baseline was associated with a substantially increased risk of subsequent ICH ( OR , 12.1 ; 95 % CI , 3.4-42.5 ; P < 0.001 ) .
O O O O O O O O O O O B-DiseaseOrPhenotypicFeature O O O O O O O O O O O B-DiseaseOrPhenotypicFeature O O O O O O O O O O O O O O O O